SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

SVB Leerink Maintains Outperform on AbbVie, Raises Price Target to $122

SVB Leerink maintains AbbVie (NYSE:ABBV) with a Outperform and raises the price target from $107 to $122.

Benzinga · 05/11/2020 10:40

SVB Leerink maintains AbbVie (NYSE:ABBV) with a Outperform and raises the price target from $107 to $122.